| Literature DB >> 24503284 |
Boaz Levy1, Selda Celen-Demirtas2, Tinatin Surguladze2, Sara Eranio2, James Ellison3.
Abstract
Cost-prohibitive factors currently prevent a warranted integration of neuropsychological screenings into routine psychiatric evaluations, as a standard of care. To overcome this challenge, the current study examined the psychometric properties of a new computerized measure-the CNS Screen. One hundred and twenty six psychiatric inpatients completed the CNS Screen, the Montreal Cognitive Assessment (MoCA), and the Quick Inventory of Depressive Symptomatology-Self Rated (QIDS-SR₁₆) on the day of hospital discharge. Statistical analysis established convergent validity with a moderate correlation between the self-administered CNS Screen and the clinician-administered MoCA (r=0.64). Discriminant validity was implicated by a non-significant correlation with the QIDS-SR₁₆. Concurrent validity was supported by a moderate, negative correlation with patients' age (r=-0.62). In addition, consistent with previous findings, patients with psychotic disorders exhibited significantly poorer performance on the CNS Screen than patients with a mood disorder. Similarly, patients with a formal disability status scored significantly lower than other patients. The CNS Screen was well tolerated by all patients. With further development, this type of measure may provide a cost-effective approach to expanding neuropsychological screenings on inpatient psychiatric units.Entities:
Keywords: Cognitive functioning; Computerized testing; Inpatients; Neuropsychological assessment; Standard of care
Mesh:
Year: 2014 PMID: 24503284 DOI: 10.1016/j.psychres.2014.01.010
Source DB: PubMed Journal: Psychiatry Res ISSN: 0165-1781 Impact factor: 3.222